These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20544931)

  • 1. Safety of influenza vaccination: Risk-benefit evaluation.
    Wiwanitkit V
    Muscle Nerve; 2010 Aug; 42(2):296; author reply 296. PubMed ID: 20544931
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety of influenza vaccination in patients with myasthenia gravis: a population-based study.
    Zinman L; Thoma J; Kwong JC; Kopp A; Stukel TA; Juurlink DN
    Muscle Nerve; 2009 Dec; 40(6):947-51. PubMed ID: 19902540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance.
    Auriel E; Regev K; Dori A; Karni A
    Muscle Nerve; 2011 Jun; 43(6):893-4. PubMed ID: 21607970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
    Press R; Andersen O
    Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
    [No Abstract]   [Full Text] [Related]  

  • 5. What we know about influenza vaccine and Guillain-Barré syndrome.
    Enos L
    Oreg Nurse; 2009 Nov; ():5. PubMed ID: 19998739
    [No Abstract]   [Full Text] [Related]  

  • 6. Avoiding Guillan-Barré Syndrome following swine origin pandemic H1N1 2009 influenza vaccination.
    Eisen DP; McBryde ES
    J Infect Dis; 2009 Nov; 200(10):1627-8. PubMed ID: 19857155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Guillain-Barré syndrome secondary to H1N1 influenza vaccine].
    López Nieto M; Gómez Garrido J; Losa Palacios A; Aguila Manso G
    Rev Clin Esp; 2010 Oct; 210(9):485-6. PubMed ID: 20832792
    [No Abstract]   [Full Text] [Related]  

  • 8. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic (H1N1) 2009 influenza.
    Polkinghorne B; Ward K; Totaro R
    N S W Public Health Bull; 2010; 21(1-2):41-2. PubMed ID: 21367344
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
    Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
    Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
    Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
    Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
    [No Abstract]   [Full Text] [Related]  

  • 12. Guillain-Barré syndrome associated with H1N1 vaccination.
    Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
    Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
    [No Abstract]   [Full Text] [Related]  

  • 13. Guillain-Barré syndrome following H1N1 immunization in a pediatric patient.
    Tremblay ME; Closon A; D'Anjou G; Bussières JF
    Ann Pharmacother; 2010; 44(7-8):1330-3. PubMed ID: 20484170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination?
    Li S; Zhu J
    Vaccine; 2012 Aug; 30(38):5585. PubMed ID: 22728223
    [No Abstract]   [Full Text] [Related]  

  • 15. Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Dec; 58(48):1351-6. PubMed ID: 20010511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
    Choe YJ; Cho H; Bae GR; Lee JK
    Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Guillain-Barre syndrome after influenza vaccination].
    Vilstrup H
    Ugeskr Laeger; 2009 May; 171(21):1801; author reply 1801. PubMed ID: 19496235
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccine update 2009: questions around the safety of the influenza A (H1N1) vaccine].
    Siegrist CA
    Rev Med Suisse; 2010 Jan; 6(231):67-70. PubMed ID: 20196437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pearls for H1N1 influenza vaccination.
    Marcotte GV
    J Allergy Clin Immunol; 2010 Apr; 125(4):951-2; author reply 952. PubMed ID: 20226509
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of antibody response to Guillain-Barré syndrome-related gangliosides in mice and men after novel flu vaccination.
    Yuki N; Takahashi Y; Ihara T; Ito S; Nakajima T; Funakoshi K; Furukawa K; Kobayashi K; Odaka M
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):116-7. PubMed ID: 21084265
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.